| Cyprumed–MC Services: public relations, 202504 service existent MC Services is media contact |
2025-04-15 |
| Merck (US)–Cyprumed: drug delivery technology, 202504– license + option agreem for oral drug delivery of peptide therapeutics |
2025-04-15 |
| Xund Solutions–J&T Ventures (CZ): investment, 202503 financing round pre-Series A totalling €6m incl new + co-investor J&T Ventures |
2025-03-05 |
| Xund Solutions–Lana Ventures: investment, 202503 financing round pre-Series A totalling €6m incl existing + co-investor Lana Ventures |
2025-03-05 |
| Xund Solutions–Lead Ventures (HU): investment, 202503 financing round pre-Series A totalling €6m incl new + lead investor Lead Ventures |
2025-03-05 |
| Xund Solutions–MassMutual: investment, 202503 financing round pre-Series A totalling €6m incl existing + co-investor MassMutual Ventures |
2025-03-05 |
| Xund Solutions–SEVERAL: investment, 202503 financing round pre-Series A €6m led by Lead Ventures |
2025-03-05 |
| Xund Solutions–Tyrolean Business Angel Network: investment, 202503 financing round pre-Series A totalling €6m incl existing + co-investor tba network |
2025-03-05 |
| Graph Therapeutics–SEVERAL: investment, 202501 pre-seed financing round $3.1m led by Squareone + Merantix Capital |
2025-01-09 |
| Invios–MC Services: public relations, 202410 service existent by MC Services |
2024-11-13 |
| Mediaire–G8Way Ventures: investment, 202411 financing round totalling €12m incl existing + co-investor Gateway Ventures |
2024-11-12 |
| UpNano–Austria (govt): investment, 202410 financing round Series A totalling €7m incl co-lead investor aws Gründungsfonds |
2024-10-17 |
| UpNano–IGO Industries: investment, 202410 financing round Series A totalling €7m incl existing + co-lead investor IGO Innovation GmbH |
2024-10-17 |
| UpNano–ILUM Tec: investment, 202410 financing round Series A totalling €7m incl existing + co-investor ILUM Tec |
2024-10-17 |
| UpNano–Merloni: investment, 202410 financing round Series A totalling €7m incl co-lead investor NovaCapital |
2024-10-17 |
| UpNano–SEVERAL: investment, 202410 financing round Series A €7m co-led by aws Gründungsfonds + NovaCapital + IGO Innovation |
2024-10-17 |
| Invios–SEVERAL: investment, 202410 financing round Series A €8.2m incl existing investors + Ligand Pharmaceuticals |
2024-10-15 |
| a:head bio–SEVERAL: investment, 202410 financing round pre-Series A 7-digit EUR from existing + new investors |
2024-10-09 |
| Clock Bio–Onsight Ventures: investment, 202410 seed financing round totalling $5.3m incl co-investor Onsight Ventures |
2024-10-09 |
| Aitiologic–Austria (govt): grant, 202306–202410 grants from aws + FFG |
2024-10-01 |
| Aitiologic–Lana Ventures: investment, 202306–202410 seed financing round incl co-lead investor LANA Ventures |
2024-10-01 |
| Aitiologic–Push Ventures: investment, 202306–202410 seed financing round incl co-lead investor PUSH VC |
2024-10-01 |
| Aitiologic–SEVERAL: investment, 202306–202410 seed financing round >€2.5m (incl aws + FFG grants) led by Push VC + Lana Ventures |
2024-10-01 |
| Erbe Elektromedizin–1BillionLives: quality management software, 202409 supply existent Erbe is customer of Flinn.ai |
2024-09-30 |
| Austrian Academy of Sciences–Boehringer: grant, 202409–203608 funding €150m establishment + operation of AITHYRA Institute over 12y by BIS |
2024-09-18 |
| Bespark Bio–Austria (govt): grant, 202409 FFG grant €381.5k |
2024-09-16 |
| Aitiologic–Siemens: liquid biopsy technology, 202409c license excl to IP related to aitios platform initially developed by founder at S Healthineers |
2024-09-01 |
| 1BillionLives–Cherry Ventures: investment, 202408 seed financing round totalling €6m incl lead investor Cherry Ventures |
2024-08-03 |
| 1BillionLives–OTHER: investment, 202408 seed financing round totalling €6m incl business angels incl M Weber + M Reitermann |
2024-08-03 |
| 1BillionLives–SEVERAL: investment, 202408 seed financing round €6m of Flinn led by Cherry Ventures |
2024-08-03 |
| 1BillionLives–Speedinvest: investment, 202408 seed financing round totalling €6m incl existing + co-investor Speedinvest |
2024-08-03 |
| 1BillionLives–SquareOne: investment, 202408 seed financing round totalling €6m incl existing + co-investor SquareOne VC |
2024-08-03 |
| Apeiron–Ligand: investment, 202407 acquisition $100m plus milestones + up to $28m royalties of Apeiron Biologics by Ligand Pharmaceuticals SIGNED |
2024-07-08 |
| Invios–Ligand: investment, 202407 investment up to €4m in InviosHolding AG by Ligand |
2024-07-08 |
| Venga Ventures–SEVERAL: investment, 202407– fund raising with max target size of €40m to €50m |
2024-07-08 |
| Ygion Biomedical–OTHER: investment, 202405 financing round Series A €15m from Austrian private trust (maybe AVV Investment??) |
2024-05-21 |
| Single Use Support–Novo Group: investment, 202405 acquisition of 60% majority share by Novo Holdings |
2024-05-15 |
| Boehringer–CBmed: cancer drugs, 202402– collab long-term strategic alliance €na using translational medicine to develop personalised cancer treatments |
2024-02-08 |
| Zetta Genomics–Apex Ventures: investment, 202402 2nd seed financing round expansion totalling £1.8m incl existing investor Apex Ventures |
2024-02-08 |
| ABS Biotechnologies–OBN: investor conference, 202401 supply service ABS Biotechnologies presents at BioSeed 2024 London |
2024-01-22 |
| Olgram–OBN: investor conference, 202401 supply service Olgram presents at BioSeed 2024 London |
2024-01-22 |
| Evomedis–MC Services: public relations, 202311 service existent by MC Services |
2023-11-23 |
| Valanx Biotech–Niederösterreich (govt): investment, 202311 growth financing totalling €2.3m equity + public funding incl existing investor TE |
2023-11-07 |
| Valanx Biotech–SEVERAL: investment, 202311 growth financing round €2.3m incl equity + public funding led by SkyGene |
2023-11-07 |
| Valanx Biotech–SkyGene: investment, 202311 growth financing round totalling €2.3m in equity + public funding incl new + lead investor SkyGene |
2023-11-07 |
| Valanx Biotech–SOSV: investment, 202311 growth financing totalling €2.3m equity + public funding incl existing investor SOSV |
2023-11-07 |
| Valanx Biotech–Xista Science Ventures: investment, 202311 growth financing round totalling €2.3m equity + public funding incl existing investor Xista |
2023-11-07 |
| HeartBeat.bio–MC Services: public relations, 202311 service existent by MC Services |
2023-11-02 |
| HeartBeat.bio–SEVERAL: investment, 202311 financing round pre-Series A €4.5m with i&i Biotech Fund + Invest AG + aws + Tensor Ventures |
2023-11-02 |
| CMBlu Energy–STRABAG: investment, 202310 equity investment €100m in connection with preferred partnership agreement |
2023-10-23 |
| STRABAG––CMBlu Energy: energy storage solutions, 202310– strategic collab preferred supplier agreement for SolidFlow batteries |
2023-10-23 |
| Biotech Austria–MC Services: public relations, 202310 service existent by MC Services |
2023-10-17 |
| Kern Tec–EU (govt): investment, 202309 financing round Series A totalling €12m incl co-investor EIC Fund |
2023-09-27 |
| Kern Tec–PeakBridge: investment, 202309 financing round Series A totalling €12m incl co-investor PeakBridge Growth 2 fund |
2023-09-27 |
| Kern Tec–SEVERAL: investment, 202309 financing round Series A €12m led by Telos Impact (eventually total includes grants?) |
2023-09-27 |
| Kern Tec–Telos Impact: investment, 202309 financing round Series A totalling €12m incl lead investor Telos Impact |
2023-09-27 |
| 1BillionLives–Austria (govt): grant, 202307–202606 3y grant €2m from FFG for Flinn |
2023-07-01 |
| Nyra Health–SEVERAL: investment, 202306 seed financing round €4.5m co-led by MassMutual Ventures + Wellington Partners |
2023-06-16 |
| Michor Consulting–QbD Group: investment, 202305 acquisition of Michor Consulting by QbD Group |
2023-05-25 |
| Brutkasten–VGN Medien: investment, 202305 acquisition of majority share by VGN Medien Holding as strategic investor |
2023-05-17 |
| Zetta Genomics–Apex Ventures: investment, 202304 2nd seed financing round totalling £1.9m incl existing + co-investor Apex Ventures |
2023-04-18 |
| Merck (US)–Proxygen: molecular glue degraders, 202304– strategic multi-year collab + license agreem upfront payment + €2.55b milestones plus royalties |
2023-04-05 |
| Proxygen–Vida Strategic Partners: public relations, 202304 service existent by Vida Strategic Partners |
2023-04-05 |
| Refined Laser Systems–Apex Ventures: investment, 202301 seed financing round totalling €2.7m incl co-lead investor Apex Medical Fund |
2023-01-26 |
| Refined Laser Systems–Onsight Ventures: investment, 202301 seed financing round totalling €2.7m incl co-investor Onsight Ventures |
2023-01-26 |
| 1BillionLives–Paua Ventures: investment, 202212 pre-seed financing round of Flinn totalling €1.8m incl co-lead investor Paua Ventures |
2022-12-01 |
| 1BillionLives–SEVERAL: investment, 202212 pre-seed financing round €1.8m of Flinn led by Speedinvest + Paua Ventures |
2022-12-01 |
| 1BillionLives–Speedinvest: investment, 202212 pre-seed financing round totalling €1.8m of Flinn incl co-lead investor Speedinvest |
2022-12-01 |
| Sarcura–Axilium Holding: investment, 202211 seed plus financing round totalling €7m incl existing + co-investor Axilium Holding |
2022-11-17 |
| Sarcura–HCVC: investment, 202211 seed plus financing round totalling €7m incl new + co-investor HCVC |
2022-11-17 |
| Sarcura–IST Cube: investment, 202211 seed plus financing round totalling €7m incl existing + co-lead investor IST Cube |
2022-11-17 |
| Sarcura–Lansdowne Partners: investment, 202211 seed plus financing round totalling €7m incl existing + co-lead investor Lansdowne Investment Co Cyprus |
2022-11-17 |
| Sarcura–Merloni: investment, 202211 seed plus financing round totalling €7m incl existing + co-investor NovaCapital |
2022-11-17 |
| Sarcura–Niederösterreich (govt): investment, 202211 seed plus financing round totalling €7m incl new + co-investor Tecnet Equity |
2022-11-17 |
| Sarcura–Nina Capital: investment, 202211 seed plus financing round totalling €7m incl existing + co-investor Nina Capital |
2022-11-17 |
| Sarcura–OTHER: investment, 202211 seed plus financing round totalling €7m incl European family offices as new investors |
2022-11-17 |
| Sarcura–SEVERAL: investment, 202211 seed plus financing round €7m co-led by Lansdowne Investment Co Cyprus + IST Cube |
2022-11-17 |
| Celeris Therapeutics–EU (govt): grant, 202210 EIC Accelerator grant €2.5m |
2022-10-19 |
| Celeris Therapeutics–EU (govt): investment, 202210 equity investment up to €10m from EIC Accelerator |
2022-10-19 |
| Xund Solutions–Lana Ventures: investment, 202209 seed financing round totalling €6m incl co-investor Lana Ventures |
2022-09-29 |
| Xund Solutions–MassMutual: investment, 202209 seed financing round totalling €6m incl co-lead investor MassMutual Ventures |
2022-09-29 |
| Xund Solutions–MMC Ventures: investment, 202209 seed financing round totalling €6m incl co-lead investor MMC Ventures |
2022-09-29 |
| Xund Solutions–Roche: investment, 202209 seed financing round totalling €6m incl co-investor RoX Health |
2022-09-29 |
| Xund Solutions–SEVERAL: investment, 202209 seed financing round €6m co-led by MMC Ventures + MassMutual Ventures |
2022-09-29 |
| BioDGraft–NLC Ventures: investment, 202209 existent seed investor NLC |
2022-09-27 |
| Boehringer–Quantro Therapeutics: cancer drugs, 202208–202507 collab + option + license agreem €na r+d small-molecule transcription factor inhibitors |
2022-08-03 |
| Biosynth Carbosynth–Eucodis Bioscience: industrial enzymes, 202208 collab existent for many years |
2022-08-02 |
| Eucodis Bioscience–Biosynth Carbosynth: investment, 202208 acquisition of Eucodis by Biosynth Carbosynth |
2022-08-02 |
| UpNano–IGO Industries: investment, 202207 capital increase with existing investors incl IGO Industries |
2022-07-05 |
| UpNano–SEVERAL: investment, 202207 capital increase with existing investors incl IGO Industries |
2022-07-05 |
| Kranus Health–Peak Pride: investment, 202206 financing round Series A totalling >$6.5m incl co-investor Peak Pride |
2022-06-20 |
| Merck (DE)–Proxygen: molecular glue degraders, 202206– strategic multi-year collab + license agreem up to €495m plus royalties |
2022-06-02 |
| Boehringer–Celeris Therapeutics: protein degradation drugs, 202204– collab AI-based drug discovery for target of Boehringer |
2022-04-04 |
| Innovacell–EU (govt): credit, 202203– venture debt loan of up to €15m from EIB to Innovacell AG |
2022-03-24 |
| Merck (DE)–Celeris Therapeutics: AI-based drug discovery, 202202– collab research small molecule binders + bifunctional degraders |
2022-03-09 |
| Marinomed–MC Services: public relations, 202202 service existent by MC Services |
2022-02-15 |
| Celeris Therapeutics–Apex Ventures: investment, 202202 seed financing round totalling $4.4m incl new + co-lead investor Apex Ventures |
2022-02-10 |
| Celeris Therapeutics–i&i Biotech Fund: investment, 202202 seed financing round totalling $4.4m incl new + co-lead investor i&i Biotech Fund |
2022-02-10 |
| Celeris Therapeutics–Longevitytech.fund: investment, 202202 seed financing round totalling $4.4m incl existing + co-investor Longevitytech.fund |
2022-02-10 |
| Celeris Therapeutics–Pace Ventures Enigma: investment, 202202 seed financing round totalling $4.4m incl new + co-lead investor Pace Ventures Enigma |
2022-02-10 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
